课题基金 / 基金详情

分子軌道法とニューラルネットワークを基盤とした薬物吸収予測システムの開発

分子軌道法とニューラルネットワークを基盤とした薬物吸収予測システムの開発
基于分子轨道法和神经网络的药物吸收预测系统开发
批准号:
11557192
负责人:
HASHIDA Mitsuru
金额:
$7.74万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B).
财政年份:
1999
资助国家:
日本
项目状态:
已结题
起止时间:
1999 至 2000

项目摘要

项目成果

HASHIDA Mitsuru的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Drug discovery and development of drugs has been time- and labor-intensitve. A key issue to solve this problem is to develop knowledge bases such as design of drug molecules and formulations. Permeability of biological membranes are important factors determining bioavailability and effectiveness of drugs. In this context, we developed mathematical models for predicting them from molecular structures of compounds. Structural descriptors of drugs were obtained by molecular orbital calculations, and the relationship between the descriptors and permeability coefficients through human skin was analyzed by multiple linear regression or artificial neural network. We revealed that dipole moment, polarizability, and atomic charges of drug molecules are important descriptors to predict skin permeability for drugs, and that a neural network model is much superior to a linear regression model in describing the descriptor/permeability relationship. This approach was applicable to prediction of permeability of Caco-2 cell monolayers, that have been used as a model of intestinal epithelium. Thus, the combination of molecular orbital calculation and neural network might be useful to predict pharmacokinetic properties of drugs. In addition, we analyzed the effect of vehicles on skin permeability of drugs based on a two-layer skin diffusion model, in which the skin is composed of stratum corneum and the lower layer, and found a close relationship between skin permeability and dielectric constant of vehicles. In conclusion, this study might be able to accelerate effectiveness of drug discovery and development, especially for topical formulations.
期刊论文(15)
专著(0)
科研奖励(0)
会议论文
Shin Nakajima: "Intratumoral pharmacokinetics of oligonucleotides in tissue-isolated tumor perfusion system"Antisense and Nucleic Acid Drug Development. (in press).
Shin Nakajima:“组织隔离肿瘤灌注系统中寡核苷酸的瘤内药代动力学”反义和核酸药物开发。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Shoichi Harada: "Effect of vehicle properties on skin penetration of emedastine"Biological and Pharmaceutical Bulletin. 23(10). 1224-1228 (2000)
Shoichi Harada:“载体特性对依美斯汀皮肤渗透的影响”生物和药物通报。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
6
    Development of novel gene-switch system inducing inflammatory tissue-selective gene expression and realizing DDS for stem cell
    • 批准号:
      25670259
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.5万
    • 财政年份:
      2013
    • 负责人:
      HASHIDA Mitsuru
    • 依托单位:
    Long-term gene expression in primary cells by transposon and its application for cell therapy
    • 批准号:
      23659284
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.41万
    • 财政年份:
      2011
    • 负责人:
      HASHIDA Mitsuru
    • 依托单位:
    Therapeutic strategy of drug delivery systems utilizing unique tumor environment
    • 批准号:
      23240072
    • 项目类别:
      Grant-in-Aid for Scientific Research (A)
    • 资助金额:
      $32.03万
    • 财政年份:
      2011
    • 负责人:
      HASHIDA Mitsuru
    • 依托单位:
    Development of bioimaging method and targeted drug delivery system for inhibiting tumor proliferation and metastasis
    • 批准号:
      17016035
    • 项目类别:
      Grant-in-Aid for Scientific Research on Priority Areas
    • 资助金额:
      $63.87万
    • 财政年份:
      2005
    • 负责人:
      HASHIDA Mitsuru
    • 依托单位:
    海外基金